MYC and neoplasm: For the correlation of CTA expression and tumor mass (i.e. ISS stage), gene expression-based risk-scores (i.e. UAMS70-gene score, Rs-score, MYC-activation index) and proliferation, as well as chromosomal aberrations (i.e. t(4;14) deletion 17p13, gain 1q21) see Figure 4.